This is common PhRMA talking point that needs perspective. Large pharmaceutical companies spend twice the their readers h budget on marketing, a good percentage of now is that is spent on patient oriented marketing. (e.g. “Talk your doctor about Xyzzy!”)
If there would be a loss of revenue, any reduction in R & D costs lies purely with c-suite’s priorities.
They spend on marketing because they are trying to sell as much as possible of the drug during the patented years. If people do not realize there's a superior drug out there, they will never part with the money for the improved treatment
Well.. yes. My point was that a person makes the decision to what to cut. Saying that eeasearch will be cut, is the same as saying marketing über alles. Punting and trying rationalize such a decision as saying “must maximize shareholder profits”, is simply myopic post hoc rationalization.
Why do I get that information from my doctor when I'm outside of US?
Why do American doctors just throw antibiotics at you, as soon as you sneeze in their office?(Getting a test for bacterial infection is cheap and fast. No bacteria - no effect by antibiotics.)
There's a lot of issues with drug awareness and appropriateness in US.
If there would be a loss of revenue, any reduction in R & D costs lies purely with c-suite’s priorities.
https://www.washingtonpost.com/news/wonk/wp/2015/02/11/big-p...